Purification of antibodies and antibody fragments using capture select™ affinity resins

Methods in Molecular Biology

Volumn 1131, Issue , 2014, Pages 297-314

  Hermans, Pim ^a   Adams, Hendrik ^a   Detmers, Frank ^a  

^a BAC BV Life Technologies   (Netherlands)

Author keywords

Affinity chromatography; Antibody fragments; Antibody purification; CaptureSelect affinity resins; Immunoaffinity chromatography

Indexed keywords

ANTIBODY; GLYCINE; IMMUNOGLOBULIN G ANTIBODY; PHOSPHATE BUFFERED SALINE; RESIN;

ANTIGEN BINDING; ARTICLE; ELUTION; FAST PROTEIN LIQUID CHROMATOGRAPHY; GENE EXPRESSION SYSTEM; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOGLOBULIN PURIFICATION; IONIC STRENGTH; PH; PRIORITY JOURNAL; PURIFICATION;

ANTIBODIES; CHROMATOGRAPHY, AFFINITY; IMMUNOGLOBULIN FRAGMENTS;

EID: 84934440651     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-992-5_19     Document Type: Article

References (21)

1. Ettre L (1993) Nomenclature for chromatography (IUPAC recommendations 1993). Pure Appl Chem 65(4):819-872
2. Hage D (1999) Affinity chromatography: a review of clinical applications. Clin Chem 45(5):593-615
3. Hjelm H, Hjelm K, Sjöquist J (1972) Protein A from Staphylococcus aureus : its isolation by affinity chromatography and its use as an immunosorbent for isolation of immunoglobulins. FEBS Lett 28(1):73-76
4. Shukla A et al (2007) Review, downstream processing of monoclonal antibodies: application of platform approaches. J Chromatogr B 848(1):28-39
5. Hober S, Nord K, Linhult M (2007) Protein A chromatography for antibody Purification. J Chromatogr B 848(1):40-47
6. Grodzki A, Berenstein E (2010) Affinity chromatography: protein A and protein G sepharose. Methods Mol Biol 588:33-41
7. Nilson B et al (1992) Protein L from Peptostreptococcus magnus binds to the kappa light chain variable domain. J Biol Chem 267(4):2234-2239
8. Hamers-Casterman C et al (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446-448
9. Muyldermans S (2001) Single domain antibodies: current status. J Biotechnol 74(4):277-302
10. van der Linden R et al (1999) Comparison of physical properties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta 1431(1):37-46
11. Frenken L et al (2000) Isolation of antigen specific Llama V H H antibody fragments and their high level secretion by Saccharomyces cerevisiae . J Biotechnol 78(1):11-21
12. Kuroiwa Y et al (2009) Antigen-specific human polyclonal antibodies from hyperimmunized cattle. Nat Biotechnol 27(2):173-181
13. Reinhart D, Weik R, Kunert R (2012) Recombinant IgA production: single step affinity Purification using camelid ligands and product characterization. J Immunol Methods 378(1-2):95-101
14. Sun Y et al (2012) Pilot production of recombinant human clotting factor IX from transgenic sow milk. J Chromatogr B 898:78-89
15. Klooster R et al (2012) Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain 135(4):1081-1101
16. Hermans P et al (2012) Reinventing affinity tags: innovative technology designed for routine Purification of C-terminal EPEA-tagged recombinant proteins. Genet Eng Biotechnol News 32(17):48-49
17. Klooster R et al (2007) Improved anti-IgG and HSA affinity ligands: clinical application of VHH antibody technology. J Immunol Methods 324(1-2):1-12
18. Beyer T et al (2009) Serum-free production and Purification of chimeric IgA antibodies. J Immunol Methods 346:26-27
19. Aitken R, Hosseini A, MacDuff R (1999) Structure and diversifi cation of the bovine immunoglobulin repertoire. Vet Immunol Immunopathol 72(1-2):21-29
20. Low D, O'Leary R, Pujar N (2007) Future of antibody Purification. J Chromatogr B 848(1): 48-63
21. Liu J et al (2009) Comparison of camelid antibody ligand to protein A for monoclonal antibody Purification. Biopharm Int 22(9): 35-43